Journal
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS
Volume 53, Issue -, Pages S138-S150Publisher
TURKISH PEDIATRICS ASSOC
DOI: 10.5152/TurkPediatriArs.2018.01814
Keywords
Bronchopulmonary dysplasia; guideline; prevention; treatment
Categories
Ask authors/readers for more resources
Scientific and technological advances in perinatology and neonatology have led to an increased rate of survival and decreased incidences of various neonatal morbidities. However, the incidence of bronchopulmonary dysplasia has remained almost the same for years in very-low-birth-weight preterm infants. Although bronchopulmonary dysplasia is the leading cause of chronic respiratory morbidity in small preterms, no substantial improvement has been achieved in prevention and treatment strategies to date. Currently, postnatal very-low-dose corticosteroids, caffeine, and vitamin A seem to be the drugs of choice, and stem cell therapy appears to be the most promising treatment modality for the future. In this guideline, which was prepared by the Turkish Neonatal Society, recent evidence-based recommendations for the prevention and treatment of bronchopulmonary dysplasia are summarized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available